Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo

Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo

IntroductionChronic lymphocytic leukemia (CLL) is characterized by an aberrant cytokine network that can support tumor growth by triggering janus kinase (JAK)/STAT pathways. Targeting cytokine-signaling should then be a rational therapeutic strategy but the JAK inhibitor ruxolitinib failed to contro...

Full description

Bibliographic Details
Main Authors:	David E. Spaner, Tina YuXuan Luo, Guizhi Wang, Gideon Schreiber, Daniel Harari, Yonghong Shi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Oncology
Subjects:	Chronic lymphocytic leukemia IL-10 cytokines toll-like receptors janus kinases cancer microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1043694/full

Similar Items

O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers
by: David E. Spaner, et al.
Published: (2021-11-01)

Persistent janus kinase‐signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial
by: David E. Spaner, et al.
Published: (2019-04-01)

Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells
by: Lindsay McCaw, et al.
Published: (2017-02-01)

Towards an inclusive cervical cancer screening strategy: Approaches for reaching socioeconomically disadvantaged women
by: Marlene Greenberg, et al.
Published: (1997-01-01)

Towards an inclusive cervical cancer screening strategy: Approaches for reaching socioeconomically disadvantaged women
by: Maureen Cava, et al.
Published: (2015-05-01)

Primary adenocarcinoma of bulbomembranous urethra: An exceedingly rare carcinoma in a male patient
by: Igor Stukalin, et al.
Published: (2019-09-01)

Case report: Diffuse hyperplastic perilobar nephroblastomatosis complicated by a unilateral Wilms tumour: diagnosis, treatment and follow-up
by: Bruce Gao, et al.
Published: (2018-06-01)

Characterization of CD200 Ectodomain Shedding.
by: Karrie K Wong, et al.
Published: (2016-01-01)

Upadacitinib as Novel Treatment for Rheumatoid Arthritis with T-Cell Granular Lymphocytic Leukemia: A Case Report and Narrative Review
by: Young Min Cho, et al.
Published: (2022-07-01)

Optimal Agronomics Increase Grain Yield and Grain Yield Stability of Ultra-Early Wheat Seeding Systems
by: Graham R. S. Collier, et al.
Published: (2021-01-01)

The Integration of Spring and Winter Wheat Genetics With Agronomy for Ultra-Early Planting Into Cold Soils
by: Graham R.S. Collier, et al.
Published: (2020-02-01)

Changes in the Amount and Distribution of Soil Nutrients and Neighbours Have Differential Impacts on Root and Shoot Architecture in Wheat (<i>Triticum aestivum</i>)
by: Habba F. Mahal, et al.
Published: (2023-07-01)

Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli
by: Andrea N. Mazzarello, et al.
Published: (2023-09-01)

Romidepsin controls chronic lymphocytic leukemia in a patient with mycosis fungoides
by: David M. Lemchak, et al.
Published: (2016-11-01)

Assessment of IL6 and TNF α in Chronic Lymphocytic Leukemia
by: Mohamed Abd-El-Haleem Mousa, et al.
Published: (2022-10-01)

VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review)
by: T. E. Byalik
Published: (2018-07-01)

The performance of spring wheat cultivar mixtures under conventional and organic management in Western Canada
by: Hua Chen, et al.
Published: (2020-01-01)

Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?
by: Marco V. Haselager, et al.
Published: (2020-10-01)

Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis
by: Ying Chi, et al.
Published: (2021-04-01)

Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2
by: Zhenghui Song, et al.
Published: (2022-04-01)

Exploring the Barriers and Facilitators Experienced by Palliative Health Care Providers Working with Patients Experiencing Homelessness during the COVID-19 Pandemic
by: Claire Rollans, et al.
Published: (2023-01-01)

Toll‐like receptor 9 signaling in chronic lymphocytic leukemia cell lines
by: Miriam Meloni, et al.
Published: (2023-12-01)

The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients
by: Serap Yalçın, et al.
Published: (2015-12-01)

TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Marta Muzio, et al.
Published: (2012-01-01)

Janus Kinases in Leukemia
by: Juuli Raivola, et al.
Published: (2021-02-01)

Prospective analysis of efficacy and safety of BR regime in the first-line treatment of chronic lymphocytic leukemia
by: E A Stadnik, et al.
Published: (2016-12-01)

Gingival Leukemic Infiltration in Chronic Lymphocytic Leukemia
by: Karima Kacem, et al.
Published: (2019-11-01)

Effect of ruxolitinib supplementation in enhancing neurogenesis via gliogenesis suppression in foetal mouse brain development
by: Hamzah, Hamizun
Published: (2019)

Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia
by: Rodolfo Patussi Correia, et al.
Published: (2014-01-01)

Meningeal involvement in chronic lymphocytic leukemia
by: S. N. Menshakova, et al.
Published: (2022-11-01)

PB2039: INFLAMMATORY MARKERS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS - A SINGLE CENTRE STUDY
by: Mariam Goubran, et al.
Published: (2023-08-01)

Infections in patients with chronic lymphocytic leukemia
by: Mariana Guarana, et al.
Published: (2023-07-01)

Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
by: Marco Herling, et al.
Published: (2022-09-01)

Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
by: Ivana Milosevic
Published: (2016-11-01)

Development of sebaceous carcinoma in a patient on ruxolitinib therapy
by: Noreen Mohsin, BS, et al.
Published: (2022-08-01)

Comparative efficacy of chronic lymphocytic leukemia treatment with or without rituximab
by: E. A. Zenkova, et al.
Published: (2019-12-01)

B-lymphocytic infiltration of the prostate to a patient with chronic lymphocytic leukemia. A case report
by: Ioannis Anastasiou, et al.
Published: (2017-03-01)

Late Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxolitinib and Steroid
by: Mauro Betelli, et al.
Published: (2020-10-01)

Deconstructing Pediatric Acute Lymphocytic Leukemia
by: David Gass, et al.
Published: (2012-03-01)

Correlation of regulatory T cells in chronic lymphocytic leukemia characterized by high-affinity CD25 expression with serum IL-2 values, IGVH mutational status, Rai stage, and therapeutic lines
by: Georgiana Ene, et al.
Published: (2020-09-01)